Inventor · disambiguated record
Elyse Marie Josee Bourque
Also filed as: BOURQUE ELYSE · BOURQUE ELYSE MARIE JOSEE · BOURQUE ELYSE MARIE JOSÉE
41 granted patents·23 pending applications·210 citations·filing 2013–2025
97Inventor score
Files withBIAL R&D INVEST S A12X4 PHARMACEUTICALS INC10GENZYME CORP9LYSOSOMAL THERAPEUTICS INC9ZYMEWORKS INC7
Top patents by PatentIndex Score
64 records- 0196US11091492B2Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Aug 17, 2021·5 cites·38 claims
- 0296US10786508B2Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2018·Granted Sep 29, 2020·10 cites·30 claims
- 0396US10751341B2Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2019·Granted Aug 25, 2020·12 cites·35 claims
- 0495US11932645B2Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2021·Granted Mar 19, 2024·2 cites·20 claims
- 0595US10759796B2CXCR4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2017·Granted Sep 1, 2020·6 cites·26 claims
- 0695US9920061B2Imidazo[1,5-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2017·Granted Mar 20, 2018·16 cites·30 claims
- 0795US9868742B2Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b] pyridazines, related compounds, and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2017·Granted Jan 16, 2018·17 cites·30 claims
- 0895US9840510B1Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2017·Granted Dec 12, 2017·16 cites·30 claims
- 0995US9522876B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2014·Granted Dec 20, 2016·19 cites·48 claims
- 1094US11351173B2Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Jun 7, 2022·3 cites·19 claims
- 1194US10570135B2Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2015·Granted Feb 25, 2020·13 cites·18 claims
- 1293US10934298B2Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disordersBIAL—BIOTECH INVEST INC·Filed 2019·Granted Mar 2, 2021·10 cites·30 claims
- 1392US11400095B2Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Aug 2, 2022·2 cites·16 claims
- 1492US11306088B2CXCR4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2020·Granted Apr 19, 2022·2 cites·21 claims
- 1592US11008316B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted May 18, 2021·6 cites·2 claims
- 1692US9879086B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2015·Granted Jan 30, 2018·11 cites·90 claims
- 1791US10787454B2Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL BIOTECH INVEST INC·Filed 2017·Granted Sep 29, 2020·10 cites·24 claims
- 1890US11453675B2Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Sep 27, 2022·2 cites·18 claims
- 1990US11168087B2Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2017·Granted Nov 9, 2021·4 cites·18 claims
- 2090US9139580B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Granted Sep 22, 2015·14 cites·1 claims
- 2189US11878979B2Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2021·Granted Jan 23, 2024·1 cites·22 claims
- 2287US9126993B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Sep 8, 2015·9 cites·1 claims
- 2386US12060349B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Granted Aug 13, 2024·1 cites·7 claims
- 2486US11192892B2Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disordersBIAL—BIOTECH INVEST INC·Filed 2017·Granted Dec 7, 2021·4 cites·18 claims
- 2586US2025066364A1Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL R&D INVEST S A·Filed 2024·Application pending·0 cites
- 2683US11124516B2Pyrrolo[1,2-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL—BIOTECH INVEST INC·Filed 2017·Granted Sep 21, 2021·4 cites·16 claims
- 2783US10201614B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2014·Granted Feb 12, 2019·3 cites·38 claims
- 2883US2024150350A1Cxcr4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2982US12303544B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2023·Granted May 20, 2025·0 cites·24 claims
- 3082US2025026749A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2024·Application pending·0 cites
- 3181US10988465B2CXCR4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2017·Granted Apr 27, 2021·1 cites·22 claims
- 3280US12152083B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2023·Granted Nov 26, 2024·0 cites·27 claims
- 3380US10414822B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2018·Granted Sep 17, 2019·2 cites·34 claims
- 3479US10450378B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2015·Granted Oct 22, 2019·2 cites·61 claims
- 3578US11780837B2CXCR4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2022·Granted Oct 10, 2023·0 cites·19 claims
- 3677US11084796B2Heterocyclic derivatives for the treatment of RSVUNIV GEORGIA STATE RES FOUND·Filed 2017·Granted Aug 10, 2021·1 cites·16 claims
- 3775US12116369B2Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activatorsBIAL—R&D INVEST S A·Filed 2021·Granted Oct 15, 2024·0 cites·22 claims
- 3874US11560422B2Sulfonamide-containing linkage systems for drug conjugatesZYMEWORKS INC·Filed 2014·Granted Jan 24, 2023·1 cites·38 claims
- 3974US10906899B2Bicyclic fused pyrazole derivatives for the treatment of RSVUNIV GEORGIA STATE RES FOUND·Filed 2017·Granted Feb 2, 2021·1 cites·19 claims
- 4072US11617777B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2019·Granted Apr 4, 2023·0 cites·23 claims
- 4172US2021261557A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Application pending·0 cites
- 4270US2023265173A1Sulfonamide-containing linkage systems for drug conjugatesZYMEWORKS BC INC·Filed 2022·Application pending·0 cites
- 4364US2021363139A1Cxcr4 inhibitors and uses thereofX4 PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4464US2020048266A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2019·Application pending·0 cites
- 4564US2025340543A1Gpr84 antagonists and uses thereofLIMINAL BIOSCIENCES LTD·Filed 2025·Application pending·0 cites
- 4662US11591405B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2019·Granted Feb 28, 2023·0 cites·18 claims
- 4762US2021403444A1Heterocyclic derivatives for the treatment of rsvUNIV GEORGIA STATE RES FOUND·Filed 2021·Application pending·0 cites
- 4858US12378229B2GPR84 antagonists and uses thereofLIMINAL BIOSCIENCES LTD·Filed 2022·Granted Aug 5, 2025·0 cites·29 claims
- 4958US2018185368A1Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 5057US2015210681A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Elyse Marie Josee Bourque files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →